Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00116103 · ClinicalTrials.gov registry record · Phase 2
A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma
A Phase 2 study of Asthma, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
NCT00116103: Completed Phase 2 study of Asthma, sponsored by Astellas Pharma.
NCT00116103 is a Phase 2 study of Asthma that has completed, run by Astellas Pharma. The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00116103, a Phase 2 study of Asthma, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
Study Summary
The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.
Conditions Studied
Interventions
- DRUG Tacrolimus Inhalation Aerosol
Study Locations (20)
California
- - Encinitas
- - Los Angeles
- - San Diego
- - San Jose
Florida
- - Daytona Beach
- - Miami
Arizona
- - Scottsdale
Colorado
- - Denver
Idaho
- - Boise
Illinois
- - River Forest
Indiana
- - South Bend
Missouri
- - St Louis
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
What the finished NCT00116103 record still lists
NCT00116103 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Tacrolimus Inhalation Aerosol is the first listed.
NCT00116103 names 20 study sites across 16 states, led by California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT00116103 about?
NCT00116103 is a clinical study titled "A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma". The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.
What is the current status of trial NCT00116103?
This trial is currently completed. It is a Phase 2 study. The study started on 2005-06. Estimated completion is 2006-04.
What conditions does trial NCT00116103 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00116103?
The interventions under investigation include: Tacrolimus Inhalation Aerosol (DRUG).
Who is sponsoring clinical trial NCT00116103?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00116103 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia